Related Experiment Video
Updated: Jun 28, 2026
11:21
Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015
Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis
Cynthia A Cordeiro1, Paula R Moreira, Germano C Costa
1Uveitis Section, Department of Ophthalmology, School of Medicine, Belo Horizonte, Brazil. cordeiro.cy@gmail.com
Molecular Vision
|October 23, 2008
Summary
Interleukin-1 (IL-1) gene polymorphisms were studied in toxoplasmic retinochoroiditis (TR). Certain IL1A genotypes linked to high IL-1a production may be associated with recurrent TR episodes.
Area of Science:
- Immunogenetics
- Ophthalmology
- Infectious Diseases
Background:
- Cytokine gene polymorphisms may influence disease susceptibility by modulating inflammatory responses.
- Interleukin-1 (IL-1) plays a significant role in the pathogenesis of toxoplasmic retinochoroiditis (TR).
Purpose of the Study:
- To investigate the association between IL1A -889 C/T and IL1B +3954C/T promoter polymorphisms and the occurrence of TR in humans.
- To determine if specific IL-1 gene variations predispose individuals to TR.
Main Methods:
- A cross-sectional study involving 100 Brazilian TR patients and 100 controls.
- Genomic DNA was analyzed using polymerase chain reaction (PCR) and PAGE to identify IL1A and IL1B polymorphisms.
Main Results:
- No significant differences in IL1A or IL1B genotype/allele distributions were found between TR patients and controls.
- A significant difference in IL1A -889 C/T genotype and allele frequencies was observed in TR patients with recurrent episodes compared to those without.
Conclusions:
- The study suggests a potential association between IL1A genotypes associated with high IL-1a production and the recurrence of TR.
- Further research is warranted to elucidate the role of IL-1 gene polymorphisms in TR pathogenesis and recurrence.
Related Concept Videos
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...